Infectious bronchitis virus vaccine
AssigneeIntervet International B.V.
InventorsLillian Melson, Faris Jirjis
Life of this patent
Estimating the term…
Abstract
Embodiments of the present invention generally relate to a novel attenuated infectious bronchitis virus (IBV) of GA-98 isolate. Further, other embodiments of the present invention generally relate to methods of immunizing avian against an infectious bronchitis virus. As well, further embodiments relate to method of making a vaccine and/or immunogenic composition for protecting avian, such as poultry, from an infectious bronchitis virus of strain GA-98.
Claims14
An infectious bronchitis vaccine for use in immunizing an avian comprising an immunogenically effective amount of the Georgia 98 (GA-98) attenuated strain deposited at the American Tissue Culture Collection under accession no. PTA-4820, and a pharmaceutically acceptable carder or diluent.
A method of producing a vaccine comprising the Georgia 98 (GA-98) attenuated strain deposited at the American Tissue Culture Collection under accession no. PTA-4820 comprising the steps of:
- inoculating a suitable substrate with the GA-98 virus strain;
- growing the strain on the substrate;
- harvesting the virus;
- and
- formulating a vaccine from the virus.
Dependencies are inferred from the claim text.